IDiyas

For the Inventor, By the Inventor

Haverhill, United Kingdom

Reginald S Richardson

USPTO Granted Patents = 12

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 99(Granted Patents)


Location History:

  • Suffolk, GB (1993 - 1996)
  • Haverhill, GB (1994 - 1998)

Company Filing History:

goldMedal12 out of 2,538 
 
Warner-lambert Company
 patents

Years Active: 1993-1998

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5726200 - Pro-drugs for CCK antagonists (1998-03-10),
2. 5631281 - N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- (1997-05-20),
3. 5622983 - N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- (1997-04-22),
4. 5593967 - Cholecystokinin antagonists, their preparation and therapeutic use (1997-01-14),
5. 5580896 - Treatment of pain and colorectal cancer with dipeptoids of (1996-12-03),
6. 5554643 - Pro-drugs for CCK antagonists (1996-09-10),
7. 5523306 - Amino acid derivatives cyclized at the C-terminal (1996-06-04),
8. 5397788 - Amino acid derivatives cyclized at the C-terminal (1995-03-14),
9. 5340825 - Pro drugs for CCK antagonists (1994-08-23),
10. 5331006 - Amino acid analogs as CCK antagonists (1994-07-19),
11. 5278316 - N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- (1994-01-11),
12. 5244915 - Amico acid derivatives cyclized at the C-terminal (1993-09-14),

Title: Reginald S Richardson: Innovator in Pharmaceutical Chemistry

Introduction

Reginald S Richardson is a notable inventor based in Haverhill, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel pro-drugs and dipeptoids. With a total of 12 patents to his name, Richardson's work has the potential to impact various therapeutic areas.

Latest Patents

Richardson's latest patents focus on pro-drugs for CCK antagonists. These innovative compounds are designed to treat conditions such as obesity, hypersecretion of gastric acid, gastrin-dependent tumors, and even serve as antipsychotics. The dipeptoids he has developed also function as antianxiety and antiulcer agents. Furthermore, they are useful in preventing withdrawal responses from chronic treatments involving substances like nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. His patents also include pharmaceutical compositions and methods for treatment, as well as processes for preparing these compounds and novel intermediates.

Career Highlights

Richardson is currently associated with Warner-Lambert Company, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential applications in treating various mental health and gastrointestinal disorders.

Collaborations

Richardson has collaborated with notable colleagues such as David Christopher Horwell and Martyn C Pritchard, contributing to the advancement of pharmaceutical research and development.

Conclusion

Reginald S Richardson's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only addresses critical health issues but also paves the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…